Drug Index

MYCOSTATIN

Generic: NYSTATIN

Marketing status: Discontinued

Structured Monograph

Approval overview MYCOSTATIN is listed in Drugs@FDA under application 060571 (ANDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength OINTMENT;TOPICAL - 100,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DELCOR ASSET CORP Submission history See approval history documents.